Shilpa Medicare informs about press release

24 Feb 2026 Evaluate
Shilpa Medicare has informed that it enclosed a press release on licensing agreement between Shilpa Biologicals (SBPL), a material subsidiary of the company, and Steincares, to commercialize its biosimilar across Latin America. The above information is also available on the website of the Company www.vbshilpa.com.

The above information is a part of company’s filings submitted to BSE.

Shilpa Medicare Share Price

332.40 9.40 (2.91%)
06-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1798.95
Dr. Reddys Lab 1303.90
Cipla 1321.75
Zydus Lifesciences 912.95
Lupin 2344.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×